Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fredricka C Martin

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Movement Disorders : Official Journal of the Movement Disorder Society|September 25, 2004
Pilot efficacy and tolerability: a randomized, placebo-controlled trial of levetiracetam for essential tremorAdrian Handforth, Fredricka C Martin
Movement Disorders : Official Journal of the Movement Disorder Society|June 15, 2006
Carbenoxolone and mefloquine suppress tremor in the harmaline mouse model of essential tremorFredricka C Martin, Adrian Handforth
Brain Research|May 14, 2004
Vagus nerve stimulation inhibits harmaline-induced tremorScott E Krahl, Fredricka C Martin, Adrian Handforth
Movement Disorders : Official Journal of the Movement Disorder Society|December 8, 2004
Harmaline-induced tremor as a potential preclinical screening method for essential tremor medicationsFredricka C Martin, Anh Thu Le, Adrian Handforth
Movement Disorders : Official Journal of the Movement Disorder Society|January 2, 2009
Zonisamide for essential tremor: an evaluator-blinded studyAdrian Handforth, Fredricka C Martin, Gail A Kang, et al.
Neuropharmacology|June 16, 2010
T-type calcium channel antagonists suppress tremor in two mouse models of essential tremorAdrian Handforth, Gregg E Homanics, Douglas F Covey, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Movement Disorders : Official Journal of the Movement Disorder Society|September 25, 2004
Pilot efficacy and tolerability: a randomized, placebo-controlled trial of levetiracetam for essential tremorAdrian Handforth, Fredricka C Martin
Movement Disorders : Official Journal of the Movement Disorder Society|June 15, 2006
Carbenoxolone and mefloquine suppress tremor in the harmaline mouse model of essential tremorFredricka C Martin, Adrian Handforth
Brain Research|May 14, 2004
Vagus nerve stimulation inhibits harmaline-induced tremorScott E Krahl, Fredricka C Martin, Adrian Handforth
Movement Disorders : Official Journal of the Movement Disorder Society|December 8, 2004
Harmaline-induced tremor as a potential preclinical screening method for essential tremor medicationsFredricka C Martin, Anh Thu Le, Adrian Handforth
Movement Disorders : Official Journal of the Movement Disorder Society|January 2, 2009
Zonisamide for essential tremor: an evaluator-blinded studyAdrian Handforth, Fredricka C Martin, Gail A Kang, et al.
Neuropharmacology|June 16, 2010
T-type calcium channel antagonists suppress tremor in two mouse models of essential tremorAdrian Handforth, Gregg E Homanics, Douglas F Covey, et al.
Pageof 1